Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions.

Bahrami A, Perez-Ordonez B, Dalton JD, Weinreb I.

Histopathology. 2013 Aug;63(2):250-62. doi: 10.1111/his.12152. Epub 2013 Jun 6.

PMID:
23738717
2.

Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts.

Katabi N, Ghossein R, Ho A, Dogan S, Zhang L, Sung YS, Antonescu CR.

Hum Pathol. 2015 Jan;46(1):26-33. doi: 10.1016/j.humpath.2014.08.017. Epub 2014 Sep 7.

3.

Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.

Chiosea SI, Thompson LD, Weinreb I, Bauman JE, Mahaffey AM, Miller C, Ferris RL, Gooding WE.

Cancer. 2016 Oct 15;122(20):3136-3144. doi: 10.1002/cncr.30179. Epub 2016 Jul 5.

4.

PLAG1 alteration in carcinoma ex pleomorphic adenoma: immunohistochemical and fluorescence in situ hybridization studies of 22 cases.

Bahrami A, Dalton JD, Shivakumar B, Krane JF.

Head Neck Pathol. 2012 Sep;6(3):328-35. doi: 10.1007/s12105-012-0353-8. Epub 2012 Apr 8.

5.
6.

Lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma: genomic profiles, gene fusions, and clinical characteristics.

von Holstein SL, Fehr A, Persson M, Nickelsen M, Therkildsen MH, Prause JU, Heegaard S, Stenman G.

Ophthalmology. 2014 May;121(5):1125-33. doi: 10.1016/j.ophtha.2013.11.037. Epub 2014 Jan 24.

PMID:
24468654
7.

Pediatric epithelial salivary gland tumors: spectrum of histologies and cytogenetics at a children's hospital.

Craver RD, Fonseca P, Carr R.

Pediatr Dev Pathol. 2010 Sep-Oct;13(5):348-53. doi: 10.2350/09-05-0654-OA.1. Epub 2010 Jan 7.

PMID:
20055685
8.

High-resolution genomic profiling of adenomas and carcinomas of the salivary glands reveals amplification, rearrangement, and fusion of HMGA2.

Persson F, Andrén Y, Winnes M, Wedell B, Nordkvist A, Gudnadottir G, Dahlenfors R, Sjögren H, Mark J, Stenman G.

Genes Chromosomes Cancer. 2009 Jan;48(1):69-82. doi: 10.1002/gcc.20619.

PMID:
18828159
9.

Aberrant PLAG1 expression in pleomorphic adenomas of the salivary gland: a molecular genetic and immunohistochemical study.

Matsuyama A, Hisaoka M, Nagao Y, Hashimoto H.

Virchows Arch. 2011 May;458(5):583-92. doi: 10.1007/s00428-011-1063-4. Epub 2011 Mar 11.

PMID:
21394649
10.

Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2/neu and MIB1 immunohistochemistry.

Di Palma S, Skálová A, Vanìèek T, Simpson RH, Stárek I, Leivo I.

Histopathology. 2005 Feb;46(2):144-52.

PMID:
15693886
11.
12.

Frequent PLAG1 gene rearrangements in skin and soft tissue myoepithelioma with ductal differentiation.

Antonescu CR, Zhang L, Shao SY, Mosquera JM, Weinreb I, Katabi N, Fletcher CD.

Genes Chromosomes Cancer. 2013 Jul;52(7):675-82. doi: 10.1002/gcc.22063. Epub 2013 Apr 30.

13.

Clear cell myoepithelial carcinoma of salivary glands showing EWSR1 rearrangement: molecular analysis of 94 salivary gland carcinomas with prominent clear cell component.

Skálová A, Weinreb I, Hyrcza M, Simpson RH, Laco J, Agaimy A, Vazmitel M, Majewska H, Vanecek T, Talarčik P, Manajlovic S, Losito SN, Šteiner P, Klimkova A, Michal M.

Am J Surg Pathol. 2015 Mar;39(3):338-48. doi: 10.1097/PAS.0000000000000364.

PMID:
25581728
14.

PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities.

Katabi N, Xu B, Jungbluth AA, Zhang L, Shao SY, Lane J, Ghossein R, Antonescu CR.

Histopathology. 2017 Aug 10. doi: 10.1111/his.13341. [Epub ahead of print]

PMID:
28796899
15.

Usefulness of translocation-associated immunohistochemical stains in the fine-needle aspiration diagnosis of salivary gland neoplasms.

Foo WC, Jo VY, Krane JF.

Cancer Cytopathol. 2016 Jun;124(6):397-405. doi: 10.1002/cncy.21693. Epub 2016 Feb 16.

16.

Heterogeneity of PLAG1 gene rearrangements in pleomorphic adenoma.

Kandasamy J, Smith A, Diaz S, Rose B, O'Brien C.

Cancer Genet Cytogenet. 2007 Aug;177(1):1-5.

PMID:
17693184
17.

Salivary duct carcinoma and the concept of early carcinoma ex pleomorphic adenoma.

Griffith CC, Thompson LD, Assaad A, Purgina BM, Lai C, Bauman JE, Weinreb I, Seethala RR, Chiosea SI.

Histopathology. 2014 Dec;65(6):854-60. doi: 10.1111/his.12454. Epub 2014 Oct 30.

PMID:
24804831
18.

HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.

Mito JK, Jo VY, Chiosea SI, Dal Cin P, Krane JF.

Histopathology. 2017 Oct;71(4):511-521. doi: 10.1111/his.13246. Epub 2017 Jul 5.

PMID:
28463429
19.

Low-grade salivary duct carcinoma or low-grade intraductal carcinoma? Review of the literature.

Kuo YJ, Weinreb I, Perez-Ordonez B.

Head Neck Pathol. 2013 Jul;7 Suppl 1:S59-67. doi: 10.1007/s12105-013-0460-1. Epub 2013 Jul 3. Review.

20.

PLAG1 expression is maintained in recurrent pleomorphic adenoma.

de Brito BS, Gaspar NG, Egal ES, Sanchez-Romero C, Martins AS, Tincani ÁJ, de Oliveira Gondak R, de Almeida OP, Kowalski LP, Altemani A, Mariano FV.

Virchows Arch. 2016 Oct;469(4):477-81. doi: 10.1007/s00428-016-1980-3. Epub 2016 Jul 6.

PMID:
27381214

Supplemental Content

Support Center